Understanding symptom clusters in ovarian cancer patients undergoing chemotherapy
Correlation Study of Symptom Clusters and Negative Emotions During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution
This study is trying to understand the different groups of symptoms that women with ovarian cancer experience while getting chemotherapy to help improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Affiliated Hospital of Jiaxing University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Jiaxing) |
| Trial ID | NCT06222008 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the symptom clusters experienced by patients with ovarian cancer who are receiving postoperative chemotherapy. Participants will complete questionnaires before starting chemotherapy and after the 1st, 3rd, and 6th treatment cycles to identify and analyze the symptoms they experience. The study also seeks to explore whether there are differences in these symptom clusters based on different Traditional Chinese Medicine (TCM) body types. By gathering this data, the study hopes to provide insights into the symptom management of ovarian cancer patients during chemotherapy.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a pathologic diagnosis of ovarian cancer who are undergoing surgery combined with chemotherapy.
Not a fit: Patients with other tumors, unclear diagnoses, or those receiving additional psychological interventions during the study may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of symptom management in ovarian cancer patients, leading to improved patient care and quality of life.
How similar studies have performed: While there is ongoing research into symptom management in cancer patients, this specific approach focusing on symptom clusters in relation to TCM body types is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Pathologic diagnosis of ovarian cancer, the treatment plan adopts surgery combined with chemotherapy. Age ≥ 18 years old, know the real situation of the disease, the expected survival period \> 1 year. General condition is good, no history of psychiatric disease, no serious heart, brain, liver, kidney function abnormality. Informed consent and voluntarily participate in this study. Exclusion Criteria: those who have other tumors or whose diagnosis is unclear. those who cannot communicate properly, understand the questionnaire or complete the scale assessment. those who receive additional psychological interventions during the study period.
Where this trial is running
Jiaxing
- The First Hospital of Jiaxing — Jiaxing, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.